Equivalents under Danish Law

Similar documents
NEW LEGISLATION AND CASE LAW in the Nordic countries DENMARK. Nicolaj Bording, attorney-at-law (L), partner, LL.M. Side 1

Doctrine of Equivalents: Recent Developments in Germany

Standing Committee on Patents. Questionnaire on the Publication of Patent Applications

Slide 13 What rights does a patent confer?

Patentable Subject Matter and Medical Use Claims in the Pharmaceutical Sector

TEMPLATE FOR PROCESSOR AGREEMENTS BETWEEN MUNICIPALITIES AND IT SUPPLIERS - version 1.0 of 3 April 2017

Patent litigation. Block 1. Module Priority. Essentials: Priority. Introduction

Europe Divided Update on National Case Law in Europe

Injunctions in cases of infringement of IPRs

Standing Committee on Patents. Questionnaire on the Publication of Patent Applications

Utilization of Prior Art Evidence on TK: Opportunities and Possibilities in the International Patent System

Doctrine of Equivalents: Recent Developments in Switzerland

The Third Amendment to the Patent Law of China. On December 27, 2008, the Standing Committee of the National People's

The opposition procedure and limitation and revocation procedures

How patents work An introduction for law students

Allowability of disclaimers before the European Patent Office

The Labour Court and Industrial Arbitration Act. Part 1 The Labour Court

Infringement of Claims: The Doctrine of Equivalents and Related Issues German Position

Patenting Software-related Inventions according to the European Patent Convention

Processing of data in relation to your application

Note concerning the Patentability of Computer-Related Inventions

Art. 123(2) EPC ADDED MATTER A US Perspective. by Enrica Bruno Patent Attorney. Steinfl & Bruno LLP Intellectual Property Law

It is all crystal clear by definition... (and don t blame us if it isn t)

... Revision,

Examiners Report on Paper DII Examiners Report - Paper D Part II

Standing Committee on Patents. Questionnaire on the Publication of Patent Applications

Remedies: Injunction and Damages. 1. General

European Patent Litigation: An overview

Candidate's Answer - DI

Foreign Patent Law. Why file foreign? Why NOT file foreign? Richard J. Melker

Unity of inventions at the EPO - Amendments to rule 29 EPC

should disclose the invention in a manner sufficiently clear and complete for it to be carried out by a person skilled in the art

R 84a EPC does not apply to filing date itself as was no due date missed. So, effective date for and contacts subject matter is

Attachment: Opinions on the Draft Amendment of the Implementing Regulations of the Patent Law of the People s Republic of China

Seeking Preliminary Injunction for Pharmaceutical Patent Infringement in Sweden

Second medical use or indication claims. [Please insert name last name in CAPITAL letters please]

Royal Society of Chemistry Law Group. Recent Case Law Relevant to Chemistry

4. COMPARISON OF THE INDIAN PATENT LAW WITH THE PATENT LAWS IN U.S., EUROPE AND CHINA

Claim interpretation by the Boards of Appeal of the EPO

Inventive Step in Korea

pct2ep.com Guide to claim amendment after EPO regional phase entry

Part II. Time limit for completing the International search. Application not searched

ti Litigating Patents Overseas: Country Specific Considerations Germany There is no "European" litigation system.

European Patent with Unitary Effect

Deferred examination of European patent applications. 2. German delegation 3. Netherlands delegation

EUROPEAN PATENT LITIGATORS ASSOCIATION (EPLIT)

Applicant Former surname (if applicable)

LIGE ADGANG. Professor, dr.jur.

Intellectual Property Law

Second medical use or indication claims. Mr. Antonio Ray ORTIGUERA Angara Abello Concepcion Regala & Cruz Law Offices Philippines

Harmonisation across Europe - comparison and interaction between the EPO appeal system and the national judicial systems

POST-GRANT AMENDMENT JOHN RICHARDS

CA/PL 7/99 Orig.: German Munich, SUBJECT: Revision of the EPC: Articles 52(4) and 54(5) President of the European Patent Office

The EU Unitary Patent System in its current state. EU-Japan Policy Seminar 22 November 2016

Proposed Computer-Implemented Invention Examination Guidelines

Presumption Of Patent Validity In Patent Litigations The New Trends

Questionnaire May 2003 Q Scope of Patent Protection. Response of the UK Group

AIPPI FORUM Berlin. September 25, Session V: Does the EPO grant trivial patents? Should the level of inventive step be increased?

Disclaimers at the EPO

Second medical use or indication claims

Patents: opposition proceedings and nullity actions a comparison between Europe and Japan

EPO Decision G 1/15 on Partial Priorities and Toxic Divisionals: Relief and Risks

PROPOSALS FOR CREATING UNITARY PATENT PROTECTION IN THE EUROPEAN UNION

ENFORCEMENT: WHEN AND WHERE TO ACT? FICPI 16 TH OPEN FORUM. Natalia Stepanova Partner Gorodissky & Partners Ltd.

XVI.3. Maintenance of the patent in amended form

Summary Report. Report Q189

America Invents Act (AIA) Post-Grant Proceedings

Patent litigation. Block 3. Module UPC Law Essentials

GLOSSARY OF INTELLECTUAL PROPERTY TERMS

The EPO approach to Computer Implemented Inventions (CII) Yannis Skulikaris Director Operations, Information and Communications Technology

Amendments in Europe and the United States

Part 1 Current Status of Intellectual Property Rights

Developments towards a unitary European patent system

EUROPEAN UNION. Brussels, 12 December 2012 (OR. en) 2011/0093 (COD) PE-CONS 72/11 PI 180 CODEC 2344 OC 70

EPO boards of appeal decisions. Date of decision 25 November 1987

An introduction to European intellectual property rights

BOARDS OF APPEAL OF THE EUROPEAN PATENT OFFICE. Datasheet for the decision of 7 July 2011 IPC: A61K 31/565, A61K 31/585, A61P 15/00

The Danish Agency for International Recruitment and Integration Njalsgade 72C Post box 2000 DK-2300 Copenhagen S

Patent Cooperation Treaty (PCT) Working Group

Netherlands. Report Q 175

DKPTO PCT-PPH Guidelines for Brazilian applicants

Intellectual Property and crystalline forms. How to get a European Patent on crystalline forms?

2015 Noréns Patentbyrå AB

E U R O L AW CONFERENCE 2018 JUNE 11, 12 & 13, MUNICH E V E N T PA R T N E R

Second medical use or indication claims

France Baker & McKenzie SCP

Overview of Trial for Invalidation and Opposition Systems in Japan. March 2017 Trial and Appeal Department Japan Patent Office

Norway. Norway. By Rune Nordengen, Bull & Co Advokatfirma AS

Preparing A Patent Application

SFIR / AIPPI 31 August Amendment of patent claims in France. Partial revocation of a claim by Court (only possibility until January 1, 2009)

UNITARY PATENT PROTECTION (UPP) PACKAGE

Summary Report Study Question Patents. Patentability of computer implemented inventions

Considerations on IP Law Enforcement in Europe

DETAILED TABLE OF CONTENTS

KSR International Co., v. Teleflex Inc. U.S. Supreme Court, April 2007

Patent Resources Group Federal Circuit Law Course Syllabus

COMPARATIVE STUDY REPORT INVENTIVE STEP (JPO - KIPO - SIPO)

OPLYSNINGSDOKUMENT VED KØB AF VIASOL PRODUKTER

Dawn of an English Doctrine of Equivalents: immaterial variants infringe

Topic 1: Challenges and Options in Patent Examination

Transcription:

Equivalents under Danish Law Peter Norgaard, Plesner Tuesday, 25 April 2017 Legislative basis Danish Patents Act 1967 s 39: The extent of the protection conferred by a patent shall be determined by the claims. For the interpretation of the claims the description may serve as a guideline. Denmark became a member of EPC as per 1 January 1990. During ratification of EPC, Danish legislator considered that s 39 corresponded to EPC article 69 and the Protocol on Interpretation. Hence, it was not considered necessary to make amendments to s 39 of the Patents Act 1967. Thus, for all practical purposes there is no difference between s 39 and EPC article 69(1). 2 1

Case law from the Danish Supreme Court (1) Dansk Elektrolyse A/S v Guldager A/S [2009] UfR 1523 Danish patent no DK 167.870 B2 process for corrosion protection of a water system.»claim 1: 1) Process for corrosion protection of a water system by electrolysis, 2) by which one applies a container which the water flows through, 3) with more electrodes connected to a power source characterised by 4) that one applies at least one cathode which contains the metal aluminium, 5) so that aluminium ions are formed by the cathode.«the defendant (Dansk Elektrolyse) claimed that it did not infringe since inter alia it used two containers instead of one, hence not fulfilling feature 2). 3 Case law from the Danish Supreme Court (2) Reasoning of the Supreme Court: It follows from s 39 of the Patents Act 1967 that the extent of the protection conferred by a patent shall be determined by the claims and that the description may serve as a guideline to the understanding of the claims. When determining the scope of the patent protection, it shall be taken into consideration what can be considered technically even equivalent to the features in the patent claims. ( ) the Supreme Court affirms that it can be established that what is essential about [the patentee s] patented process for corrosion protection of a water system is the electrolytic forming of aluminium ions by a cathode containing aluminium. The character of this process is not crucially changed by the defendant s design (..). The application of two containers ( ) does either not bring the designs outside the scope of the wording of the claim or can at least be considered technically equivalent solutions which as such are obvious to a person skilled in the art. 4 2

Case law from the Danish Supreme Court (3) Hence, a 4 point test is applied in relation to claim equivalents: 1) Divide the claim into features. 2) Ask what is essential in the patented invention. In Denmark, court appointed (neutral) experts are almost always used to determine this. 3) Ask whether the patented invention is crucially changed by the design in dispute. Presumably at least the essential features must have been copied. 4) Ask whether the design in dispute was obvious to a person skilled in the art. But patent obtained by the defendant did not prevent infringement. This approach allows for going outside the wording of the claims to a certain extent. 5 Case law from the Danish Supreme Court (4) The Supreme Court explicitly rejects an approach where the patent protection is determined by what is the core of the invention, i.e. an approach where the patent claims are mere sign poles in the determination of the patent protection. Moreover, the Supreme Court explicitly stated that it was of no importance that the defendant s invention had been considered new and inventive by the EPO. 6 3

Case law from the Danish Supreme Court (5) Albert Hedegaard v Hardi International A/S [2014] UfR 488 Danish Patent no. DK 156806 C crop sprayer. The Supreme Court Confirmed that equivalent solutions could be taken into considerations when determining the scope of the patent protection. Moreover, the Supreme Court stated: If the wording of the patent claims is unclear, it can be taken into consideration if the patentee towards the PTO has alleged a limited construction of unclear expressions in the patent claims in order to fulfil the requirements of novelty and inventive step... 7 A few remarks about the drospirenone case in Danmark Ruling of the High Court of 13 February 2015, case B-435-14 (unpublished, appeal from the Bailiff's Court in preliminary injunction proceedings) No infringement. The '840 patent (dehydration of water): "( ) [the patentee] has not shown that it is likely that the manufacturing drospirenone by dehydration of water from the intermediary product 5-β-OH-DRSP infringes [the patentee's] rights according to the ['840 patent]. The High Curt considers that that Bayer's original patent application concerned adding an acid or Lewis-acid to 5-β-OH- DRSP. Under the opposition/appeal proceedings before the European Patent Office (EPO) Bayer amended the description to concern adding P-Toluenesulfonic acid to 5-β-OH-DRSP. (...) In this respect, the High Chourt has not considereded that the conceptual difference between acids and bases to be decisive." 8 4

Plesner Plesner Advokatfirma Amerika Plads 37 2100 København Ø Denmark T: +45 33 12 11 33 Fax: +45 33 12 00 14 CVR: 42 93 85 13 www.plesner.com Informationerne i denne præsentation er af generel karakter og er ikke at forveksle med juridisk rådgivning. Anvendelse af præsentationens informationer sker på eget ansvar. Du er velkommen til at kontakte Plesner ved behov for rådgivning. 5